Trimethoprim-induced aseptic meningism.
Foundation Doctor, Department of Geriatric Medicine, King's College Hospital, London SE5 9RS.
Mary
M
Ni Lochlainn
Consultant, Department of Immunology, King's College Hospital, London.
Hock C
HC
Gooi
Post-doctoral Research Associate, Pathology Sciences, Drug Safety and Metabolism, AstraZeneca R&D, Cambridge Science Park, Cambridge.
Monday O
MO
Ogese
Reader, Department of Pharmacology, University of Liverpool, Liverpool.
Dean J
DJ
Naisbitt
Consultant, Department of Endocrinology, King's College Hospital, London.
Bahram
B
Jafar-Mohammadi
D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008580:Meningism / Q000139:chemically induced*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000009:adverse effects*
D000900:Anti-Bacterial Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination